Showing results (1-10 of 6,708) with videos related to

Sort By:
Pageof 671
Oncotargets and Therapy|March 19, 2021
Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract CancerPoshita-Kumari Seesaha, Kang-Xin Wang, Guo-Qun Wang, et al.
Oncotargets and Therapy|December 2, 2021
Targeted Treatment of Non-Small Cell Lung Cancer: Focus on Capmatinib with Companion DiagnosticsMatthew Z Guo, Kristen A Marrone, Alexander Spira, et al.
Oncotargets and Therapy|December 3, 2021
Erratum: Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Oncotargets and Therapy|November 26, 2021
HER2 Amplification in Advanced NSCLC Patients After Progression on EGFR-TKI and Clinical Response to EGFR-TKI Plus Pyrotinib Combination TherapyJiadi Gan, Yihua Huang, Jun Liao, et al.
Oncotargets and Therapy|November 8, 2021
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell TransplantationXin-Yue Zhang, Hai-Ping Dai, Ling Zhang, et al.
Oncotargets and Therapy|November 23, 2018
Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosisLan Li, Yu Cao, Hourong Zhou, et al.
Oncotargets and Therapy|November 23, 2018
Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapyHanping Wang, Li Zhang, Xiaoyan Si, et al.
Oncotargets and Therapy|November 23, 2018
Clinical and molecular characteristics associated with the efficacy of PD-1/PD-L1 inhibitors for solid tumors: a meta-analysisYi Ming Weng, Min Peng, Meng Xue Hu, et al.
Oncotargets and Therapy|November 23, 2018
BMP-2 inhibits lung metastasis of osteosarcoma: an early investigation using an orthotopic modelQisheng Xiong, Xuesong Wang, Lizhen Wang, et al.
Oncotargets and Therapy|November 23, 2018
Successful alternative treatment for relapsed adult acute lymphoblastic leukemia with dendritic cells-cytokine-induced killer cells combined with a rituximab-based regimenXiaoFang Xiao, XingNong Ye, Cheng Xu, et al.
Pageof 671